Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Operating Expenses | 6,346 | 6,889 | 5,847 | 6,729 | 6,545 |
| Operating Income | -6,346 | -6,889 | -5,847 | -6,729 | -6,545 |
| Interest Expense | 336 | 332 | 329 | 265 | 165 |
| Other Income | -310 | 373 | 197 | 1,129 | 5,353 |
| Pre-tax Income | -6,992 | -6,848 | -5,979 | -5,865 | -1,357 |
| Net Income Continuous | -6,992 | -6,848 | -5,979 | -5,865 | -1,357 |
| Net Income | $-6,992 | $-6,848 | $-5,979 | $-5,865 | $-1,357 |
| EPS Basic Total Ops | -0.30 | -0.29 | -0.31 | -0.27 | -0.09 |
| EPS Basic Continuous Ops | -0.30 | -0.29 | -0.31 | -0.27 | -0.09 |
| EPS Diluted Total Ops | -0.30 | -0.29 | -0.03 | -0.27 | -0.09 |
| EPS Diluted Continuous Ops | -0.30 | -0.29 | -0.31 | -0.27 | -0.09 |
| EBITDA(a) | $-6,313 | $-6,778 | $-5,678 | $-6,604 | $-6,479 |